Quanex Building Products Corporation Common Stock (NX)
16.52
+1.44 (9.55%)
NYSE · Last Trade: Dec 12th, 5:21 PM EST
Detailed Quote
Previous Close
15.08
Open
20.00
Bid
16.40
Ask
16.52
Day's Range
16.25 - 20.42
52 Week Range
11.04 - 29.67
Volume
3,309,201
Market Cap
555.01M
PE Ratio (TTM)
-2.565
EPS (TTM)
-6.4
Dividend & Yield
0.3200 (1.94%)
1 Month Average Volume
741,364
Chart
About Quanex Building Products Corporation Common Stock (NX)
Quanex Building Products Corp is a leading manufacturer of engineered materials and components for the building products industry. The company specializes in producing energy-efficient window and door components, as well as providing a range of innovative solutions designed to enhance the performance and sustainability of residential and commercial buildings. With a commitment to quality and innovation, Quanex focuses on delivering products that improve energy efficiency, durability, and overall performance, catering to the needs of builders, contractors, and manufacturers in the construction sector. Through its advanced manufacturing processes and strong customer relationships, Quanex aims to contribute to the evolution of sustainable building practices. Read More
Shares of building products company Quanex (NYSE:NX)
jumped 8.4% in the afternoon session after it reported strong third-quarter results that significantly beat analyst expectations for both earnings and revenue.
As the US market prepares to open on Friday, let's get an early glimpse into the pre-market session and identify the stocks leading the pack in terms of gains and losses.
Building products company Quanex (NYSE:NX) reported revenue ahead of Wall Streets expectations in Q3 CY2025, but sales were flat year on year at $489.8 million. Its non-GAAP profit of $0.83 per share was 61.2% above analysts’ consensus estimates.
Shares of building products company Quanex (NYSE:NX)
jumped 3.3% in the morning session after investor anticipation built ahead of the company's fourth-quarter and full-year 2025 earnings results. The building products company was scheduled to release its financial report after the market closed. Analysts had projected that Quanex's revenue would decline by 4.6% year-on-year to approximately $469.3 million. Meanwhile, expectations for adjusted earnings were set around $0.51 to $0.52 per share. The upward movement in the stock price suggested that investors were positioning themselves with a hopeful outlook before the official numbers became public.
Shares of building products company Quanex (NYSE:NX)
jumped 3.8% in the afternoon session after positive technical signals and investor optimism about future earnings growth outweighed mixed historical data.
HOUSTON, Nov. 26, 2025 (GLOBE NEWSWIRE) -- Quanex Building Products Corporation (NYSE: NX) (“Quanex” or the “Company”) today announced plans to release its fourth quarter and full year 2025 results on Thursday, December 11, 2025, after trading closes on the New York Stock Exchange.
Investors looking for hidden gems should keep an eye on small-cap stocks because they’re frequently overlooked by Wall Street.
Many opportunities exist in this part of the market, but it is also a high-risk, high-reward environment due to the lack of reliable analyst price targets.
NEW YORK - November 18, 2025 ( NEWMEDIAWIRE ) - Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Quanex Building Products Corporation (“Quanex” or “the Company”) (NYSE: NX) and certain of its officers.
Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Quanex Building Products Corporation (“Quanex” or the “Company”) (NYSE: NX) and reminds investors of the November 18, 2025 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.
Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of securities of Quanex Building Products Corporation (NYSE: NX) between December 12, 2024 and September 5, 2025, inclusive (the “Class Period”). Quanex is an international supplier of engineered home components and access solutions to the construction industry.
NEW YORK, Nov. 17, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Cytokinetics, Incorporated (NASDAQ:CYTK), Quanex Building Products Corporation (NYSE:NX), Freeport-McMoran Inc. (NYSE:FCX), and Primo Brands Corporation (NYSE:PRMB). Stockholders have until the deadlines below to petition the court to serve as lead plaintiff. Additional information about each case can be found at the link provided.
The Law Offices of Frank R. Cruz reminds investors of the upcoming November 18, 2025 deadline to participate as a lead plaintiff in the securities fraud class action lawsuit filed on behalf of investors who acquired Quanex Building Products Corporation (“Quanex” or the “Company”) (NYSE: NX) securities between December 12, 2024 and September 5, 2025, inclusive (the “Class Period”).
LOS ANGELES, Nov. 17, 2025 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Quanex Building Products Corporation (“Quanex” or ���the Company”) (NYSE: NX) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
NEW YORK - November 14, 2025 ( NEWMEDIAWIRE ) - Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Quanex Building Products Corporation (“Quanex” or “the Company”) (NYSE: NX) and certain of its officers.
NEW YORK, Nov. 14, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Cytokinetics, Incorporated (NASDAQ:CYTK), Quanex Building Products Corporation (NYSE:NX), Freeport-McMoran Inc. (NYSE:FCX), and Primo Brands Corporation (NYSE:PRMB). Stockholders have until the deadlines below to petition the court to serve as lead plaintiff. Additional information about each case can be found at the link provided.
LOS ANGELES, Nov. 13, 2025 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Quanex Building Products Corporation (“Quanex” or “the Company”) (NYSE: NX) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
NEW YORK - November 11, 2025 ( NEWMEDIAWIRE ) - Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Quanex Building Products Corporation (“Quanex” or “the Company”) (NYSE: NX) and certain of its officers.
